On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
The recent communication regarding the recent Anti-SARS-CoV-2 Total assay in Tampa has brought about...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...